Basically Stemlife is here to stay for a long time. As i have said Cordlife sees great future but they want it all for themself. Taking it private also mean doing a lot more without having to face both the shareholders and the securities commission. More can be achieved this way and when they want to cash out again, they relist when the situation is much better ie when regenerative medicine industry is booming.

If Stemlife is still listed, 3 years is the minimum. There is no other counter that deals with stem cells and hence no competitor. TMC does NOT have any stem cell business anymore.

The present board of directors is definitely more professionally qualified. Except I don't know whether they are more loyal to Cordlife or dedicated to rejunavate Stemlife. The business is ongoing and the staff are working hard. One client of cord tissue banking is worth 3 of cord blood. I hope they cannot gather enough shares to take it private. I want the board to give more back to loyal shareholders. The board have not explained to the sharehokders why it is so important to take it private. Perhaps they want to enrich Cordlife and themselves. They should offer in exchange some cordlife shares.

Look at Japan, the govt. is supporting their Regenerative Medicine industry. They are buying biotech companies dealing with stem cells. Even Mesoblast of Australia is going to Japan get their products commercially available. Cordlife is doing well making profits and expanding in Asia. So you think they will lose money in Stemlife?? They want to buy cheap lah. The reg med industry will definitely grow in the near future.

Do not sell this counter. Cordlife has bigger plans but want it cheap. The regenerative industry is starting to pick up. The assets of this company is substantial,cash and real estate. The business is still profitable. If not Cordlife would not buy.